AWSYX | RWIHX | AWSYX / RWIHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 9 years | - |
Gain YTD | 17.479 | 14.346 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 630M | 128B | 0% |
Annual Yield % from dividends | 0.50 | 1.86 | 27% |
Returns for 1 year | 28.90 | 24.96 | 116% |
Returns for 3 years | 4.92 | 9.49 | 52% |
Returns for 5 years | 19.31 | 46.52 | 42% |
Returns for 10 years | 15.08 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PMBSX | 44.38 | -0.16 | -0.36% |
Principal MidCap R4 | |||
CWCFX | 17.73 | -0.07 | -0.39% |
Christopher Weil & Co Core Investment | |||
TGVRX | 28.13 | -0.12 | -0.42% |
Thornburg International Equity R3 | |||
FRBRX | 161.82 | -0.94 | -0.58% |
Franklin Biotechnology Discovery R6 | |||
MFLLX | 12.16 | -0.16 | -1.30% |
Morgan Stanley Inst Inception R6 |